High Paxlovid costs and prescribing barriers limit access for older adults and high-risk patients, despite continued free ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Joe Biden has COVID-19 again and is using Paxlovid, the Pfizer medication that has been widely used in the treatment of COVID symptoms since 2021. The reassurance that the president, who is at ...

Pfizer said Paxlovid sales fell $1.5 billion, or 75%, to roughly $500 million, partly due to a lower rate of COVID-19 infections in the U.S. and a drop in purchases by governments. To be sure ...

Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, ...

Demand for the drugmaker’s Paxlovid treatment spurred by the latest COVID wave and a U.S. national stockpile delivery led to $2.7 billion in sales for the drug, Pfizer said Tuesday. The company ...

A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according to a study by Stanford University researchers. Currently, there are no proven ...

Paxlovid’s value to vaccinated patients isn’t yet clear, and Pfizer’s covid vaccine doesn’t entirely prevent infections, although each booster temporarily restores some protection.

Pfizer's Paxlovid Fails as 15-Day Treatment for Long COVID, Study Finds By Michael Erman (Reuters) - A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the ...

Friday will still feel brisk, with daytime highs only in the mid- to upper 50s, but most of Southeast Michigan will be rain-free. (WDIV) Read full article: Never giving up: One woman’s mission ...